StemGen, Inc. reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported net loss was USD 0.136027 million compared to USD 0.086674 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -.--% | -.--% | -.--% |
2022 | D3eSports Announces Supporting Partnership With United States Esports Federation | CI |
2022 | StemGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.57M | |
+5.88% | 63.57B | |
+4.96% | 14.09B | |
+32.75% | 8.7B | |
+1.34% | 6.37B | |
-8.98% | 5.21B | |
-16.28% | 4.39B | |
-0.89% | 4.04B | |
+8.26% | 3.78B | |
+1.72% | 3.29B |
- Stock Market
- Equities
- SGNI Stock
- News StemGen, Inc.
- StemGen, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021